We are pleased to announce the successful completion of the merger of Taro with Sun Pharma.

Read more here: https://bit.ly/pressreleasetaromerger

The results from a Phase I study evaluating the safety, tolerability, pharmacokinetics & pharmacodynamics of our GL0034 (Utreglutide) in obese adults, were presented at the 84th Scientific Sessions of the American Diabetes Association (ADA).
https://bit.ly/45FqtcO

Sun Pharma has entered into a non-exclusive patent licensing agreement with Japanese pharmaceutical company, Takeda to introduce a novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India.

Read more here: https://bit.ly/3xoMY99

Happy International Yoga Day!

Whether you're at your work desk or at home, take a break, breathe deeply, and feel the difference.

#InternationalYogaDay

As a part of #AcneAwarenessMonth, our U.S team hosted an event in New York with Dr. Sandra Lee.
She continues to collaborate with Sun Pharma to educate consumers on the role of sebum in causing acne breakouts through informative ‘edutainment.’ Read more: http://bit.ly/4ctrmHr

Sun Pharma & Moebius Medical Limited today presented data demonstrating the durability of pain relief achieved in symptomatic knee OA patients through 26 weeks post injection of MM-II at the European Alliance of Associations for Rheumatology (EULAR) 2024. http://bit.ly/4cnqqEj

We’re all about fostering inclusive growth opportunities & empowering everyone to reach their full potential. We’re committed to creating an environment where everyone can thrive & feel fully supported. Join us in celebrating the incredible women at Sun, today & every day.

Excited to see our European HR team come together in Netherlands and collaborate to learn, connect and grow together!
#WeAreSun #TogetherWeShineBrightest